Quick Answer
Ocean Biomedical, Inc. reported Total Assets of $902.0 thousand for the year ending 2024.
- Ocean Biomedical, Inc. showed a decrease of -83.6% in Total Assets from 2023 to 2024.
- This data is from Ocean Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on April 8, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $108.94 million | Q1 2022: $108.34 million | Q2 2022: $108.56 million | Q3 2022: $109.13 million | Q1 2023: $24.98 million | Q2 2023: $20.92 million | Q3 2023: $1.03 million | Q1 2024: $2.95 million | Q2 2024: $1.85 million | Q3 2024: $1.13 million | Q4 2024: $902.0 thousand | Q1 2025: $1.58 million.
- Over the full 4 years of available data (2021 to 2024), Ocean Biomedical, Inc.'s Total Assets has declined by 99.2%.
- Historical annual values: Fiscal year 2024: $902.0 thousand | Fiscal year 2023: $5.50 million | Fiscal year 2022: $1.84 million | Fiscal year 2021: $108.65 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: